RAC 1.11% $1.83 race oncology ltd

RAC - Charts & Price Action, page-21447

  1. 935 Posts.
    lightbulb Created with Sketch. 10727
    You make good points, my man. Keep it up.

    Magrolimab was purchased after P1b results and breakthrough therapy designation. None of us know what will happen. If the results are excellent and indeed prove CPACS, then we may not make it long after the world knows. My understanding of pharma is they are aggressive when it comes to first-in-class products with significantly decreased clinical risk factors like deaths, massive markets, and no clinical competitors.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.